ACTG Publications

TitleAuthorsDateJournalIssueVolume
Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.Smith, Davey M ; Strain, Matthew C ; Frost, Simon D W ; Pillai, Satish K ; Wong, Joseph K ; Wrin, Terri ; Liu, Yang ; Petropolous, Christos J ; Daar, Eric S ; Little, Susan J ; Richman, Douglas D2006 Nov 10Virology1355
Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study.Taiwo, Babafemi O ; Chan, Ellen S ; Fichtenbaum, Carl J ; Ribaudo, Heather ; Tsibris, Athe ; Klingman, Karin L ; Eron, Joseph J ; Berzins, Baiba ; Robertson, Kevin ; Landay, Alan ; Ofotokun, Igho ; Brown, Todd ; AIDS Clinical Trials Group A5303 Study Team2015 Oct 1Clin Infect Dis761
Leveraging prognostic baseline variables to gain precision in randomized trials.Colantuoni, Elizabeth ; Rosenblum, Michael2015 Aug 15Stat Med1834
Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy.Livingston, Elizabeth G ; Cohn, Susan E ; Yang, Yang ; Watts, Heather D ; Bardeguez, Arlene D ; Jones, Theodore B ; Smith, Laura M ; Umbleja, Triin ; McComsey, Grace A2007 AugObstet Gynecol2 Pt 1110
Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.Stein, James H ; Komarow, Lauren ; Cotter, Bruno R ; Currier, Judith S ; Dubé, Michael P ; Fichtenbaum, Carl J ; Gerschenson, Mariana ; Mitchell, Carol K C ; Murphy, Robert L ; Squires, Kathleen ; Parker, Robert A ; Torriani, Francesca J ; ACTG 5152s Study Team2008 DecJ Clin Lipidol62
Long-term body composition changes in antiretroviral-treated HIV-infected individuals.Grant, Philip M ; Kitch, Douglas ; McComsey, Grace A ; Collier, Ann C ; Bartali, Benedetta ; Koletar, Susan L ; Erlandson, Kristine M ; Lake, Jordan E ; Yin, Michael T ; Melbourne, Kathy ; Ha, Belinda ; Brown, Todd T2016 Nov 28AIDS1830
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.Dubé, Michael P ; Komarow, Lauren ; Mulligan, Kathleen ; Grinspoon, Steven K ; Parker, Robert A ; Robbins, Gregory K ; Roubenoff, Ronenn ; Tebas, Pablo ; Adult Clinical Trials Group 3842007 Aug 15J Acquir Immune Defic Syndr545
Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals.Grant, Philip M ; Kitch, Douglas ; McComsey, Grace A ; Collier, Ann C ; Koletar, Susan L ; Erlandson, Kristine M ; Yin, Michael T ; Bartali, Benedetta ; Ha, Belinda ; Melbourne, Kathy ; Brown, Todd T2016 Aug 15J Infect Dis4214
Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s).Clifford, David B ; Evans, Scott ; Yang, Yijun ; Acosta, Edward P ; Ribaudo, Heather ; Gulick, Roy M ; A5097s Study Team2009 Nov-DecHIV Clin Trials610
Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection.Lok, Judith J ; Bosch, Ronald J ; Benson, Constance A ; Collier, Ann C ; Robbins, Gregory K ; Shafer, Robert W ; Hughes, Michael D ; ALLRT team2010 Jul 31AIDS1224
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.Bartlett, John A ; Ribaudo, Heather J ; Wallis, Carole L ; Aga, Evgenia ; Katzenstein, David A ; Stevens, Wendy S ; Norton, Michael R ; Klingman, Karin L ; Hosseinipour, Mina C ; Crump, John A ; Supparatpinyo, Khuanchai ; Badal-Faesen, Sharlaa ; Kallungal, Beatrice A ; Kumarasamy, Nagalingeswaran2012 Jul 17AIDS1126
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.Kumarasamy, Nagalingeswaran ; Aga, Evgenia ; Ribaudo, Heather J ; Wallis, Carole L ; Katzenstein, David A ; Stevens, Wendy S ; Norton, Michael R ; Klingman, Karin L ; Hosseinipour, Mina C ; Crump, John A ; Supparatpinyo, Khuanchai ; Badal-Faesen, Sharlaa ; Bartlett, John A2015 May 15Clin Infect Dis1060
Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection.Boswell, Kristin L ; Paris, Robert ; Boritz, Eli ; Ambrozak, David ; Yamamoto, Takuya ; Darko, Sam ; Wloka, Kaska ; Wheatley, Adam ; Narpala, Sandeep ; McDermott, Adrian ; Roederer, Mario ; Haubrich, Richard ; Connors, Mark ; Ake, Julie ; Douek, Daniel C ; Kim, Jerome ; Petrovas, Constantinos ; Koup, Richard A2014 JanPLoS Pathog110
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation.Grant, Philip M ; Kitch, Douglas ; McComsey, Grace A ; Dubé, Michael P ; Haubrich, Richard ; Huang, Jeannie ; Riddler, Sharon ; Tebas, Pablo ; Zolopa, Andrew R ; Collier, Ann C ; Brown, Todd T2013 NovClin Infect Dis1057
Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.Siddique, M Atif ; Hartman, Kelly E ; Dragileva, Ella ; Dondero, Marla ; Gebretsadik, Tebeb ; Shintani, Ayumi ; Peiperl, Laurence ; Valentine, Fred ; Kalams, Spyros A2006 Sep 1J Infect Dis5194
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients.Halvas, Elias K ; Wiegand, Ann ; Boltz, Valerie F ; Kearney, Mary ; Nissley, Dwight ; Wantman, Michael ; Hammer, Scott M ; Palmer, Sarah ; Vaida, Florin ; Coffin, John M ; Mellors, John W2010 MarJ Infect Dis5201
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.Wohl, D A ; Kendall, M A ; Andersen, J ; Crumpacker, C ; Spector, S A ; Feinberg, J ; Alston-Smith, B ; Owens, S ; Chafey, S ; Marco, M ; Maxwell, S ; Lurain, N ; Jabs, D ; Benson, C ; Keiser, P ; Jacobson, M A ; A5030 Study Team2009 May-JunHIV Clin Trials310
Lower CD4 cell count and higher virus load, but not antiretroviral drug resistance, are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALLRT) analysis.Swindells, Susan ; Jiang, Hongyu ; Mukherjee, A Lisa ; Winters, Mark ; Bosch, Ronald J ; Katzenstein, David2011 Mar-AprHIV Clin Trials212
Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.Anthony, D D ; Umbleja, T ; Aberg, J A ; Kang, M ; Medvik, K ; Lederman, M M ; Peters, M G ; Koziel, M J ; Overton, E T2011 Apr 27Vaccine1929
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.Li, Jonathan Z ; Paredes, Roger ; Ribaudo, Heather J ; Svarovskaia, Evguenia S ; Metzner, Karin J ; Kozal, Michael J ; Hullsiek, Kathy Huppler ; Balduin, Melanie ; Jakobsen, Martin R ; Geretti, Anna Maria ; Thiebaut, Rodolphe ; Ostergaard, Lars ; Masquelier, Bernard ; Johnson, Jeffrey A ; Miller, Michael D ; Kuritzkes, Daniel R2011 Apr 6JAMA13305
Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP.Boltz, Valerie F ; Bao, Yajing ; Lockman, Shahin ; Halvas, Elias K ; Kearney, Mary F ; McIntyre, James A ; Schooley, Robert T ; Hughes, Michael D ; Coffin, John M ; Mellors, John W ; OCTANE/A5208 Team2014 Mar 1J Infect Dis5209
The lymph node in HIV pathogenesis.Lederman, Michael M ; Margolis, Leonid2008 JunSemin Immunol320
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.Tsibris, Athe M N ; Paredes, Roger ; Chadburn, Amy ; Su, Zhaohui ; Henrich, Timothy J ; Krambrink, Amy ; Hughes, Michael D ; Aberg, Judith A ; Currier, Judith S ; Tashima, Karen ; Godfrey, Catherine ; Greaves, Wayne ; Flexner, Charles ; Skolnik, Paul R ; Wilkin, Timothy J ; Gulick, Roy M ; Kuritzkes, Daniel R2009 Mar 1Clin Infect Dis548